Volume 385, Issue 9976, Pages (April 2015)

Slides:



Advertisements
Similar presentations
Crohn's disease Prof Daniel C Baumgart, MD, Prof William J Sandborn, MD The Lancet Volume 380, Issue 9853, Pages (November 2012) DOI: /S (12)
Advertisements

Cytotoxic therapy for severe swine flu A/H1N1
Volume 379, Issue 9824, Pages (April 2012)
Volume 384, Issue 9961, Pages (December 2014)
Volume 390, Issue 10098, Pages (September 2017)
Pharmacogenetics and future drug development and delivery
Volume 349, Issue 9057, Pages (April 1997)
Preventive malaria treatment for contacts of patients with Ebola virus disease in the context of the west Africa 2014–15 Ebola virus disease response:
Hyperbaric Oxygenation in Cardiac and Pulmonary Disease
Ann Intern Med. 2016;165(4): doi: /M Figure Legend:
A Solitary Pulmonary Mass in Multiple Myeloma*
Objectives Describe the cardiovascular monitoring techniques used in the care of critically ill patients and how to interpret the results of hemodynamic.
Volume 376, Issue 9734, Pages (July 2010)
Volume 10, Issue 12, Pages (December 2011)
Red Wine Prevents the Acute Negative Vascular Effects of Smoking
Simple versus complex COPD: implications for health-care management
Human asymptomatic Ebola infection and strong inflammatory response
Optimum timing of treatment for hepatitis C infection relative to liver transplantation  Dr Audrey Coilly, MD, Bruno Roche, MD, Prof Jean-Charles Duclos-Vallée,
Clopidogrel-Induced Systemic Inflammatory Response Syndrome
Controlling Ebola: key role of Ebola treatment centres
Volume 376, Issue 9734, Pages (July 2010)
John N Nkengasong, Philip Onyebujoh  The Lancet 
C.-P. Kuo, C.-L. Wu, H.-T. Ho, C.G. Chen, S.-I. Liu, Y.-T. Lu 
Corticosteroids in the Treatment of Alcohol-Induced Rhabdomyolysis
Effect of acute Zika virus infection on sperm and virus clearance in body fluids: a prospective observational study  Guillaume Joguet, MD, Jean-Michel.
Daratumumab for POEMS Syndrome
Characteristics and survival of patients with Ebola virus infection, malaria, or both in Sierra Leone: a retrospective cohort study  Matthew Waxman, MD,
Ebola: fever definitions might delay detection in non-epidemic areas
Sub-inner limiting membrane haemorrhages
Increased body-mass index in patients with narcolepsy
Volume 79, Issue 2, Pages (February 1981)
Acute liver failure, multiorgan failure, cerebral oedema, and activation of proangiogenic and antiangiogenic factors in a case of Marburg haemorrhagic.
Trends in virological and clinical outcomes in individuals with HIV-1 infection and virological failure of drugs from three antiretroviral drug classes:
Volume 386, Issue 10012, Pages (December 2015)
Ebola: fever definitions might delay detection in non-epidemic areas
Organisation of the care of patients with heart failure
A Phase I Study Evaluating the Safety, Pharmacokinetics, and Clinical Response of a Human IL-12 p40 Antibody in Subjects with Plaque Psoriasis  Catharine.
Procalcitonin, C-reactive protein and APACHE II score for risk evaluation in patients with severe pneumonia  F.M. Brunkhorst, B. Al-Nawas, F. Krummenauer,
Volume 379, Issue 9835, Pages (June 2012)
Statins and C-reactive protein
Volume 379, Issue 9822, Pages (March 2012)
DEPARTMENT OF ERROR The Lancet Volume 362, Issue 9385, (August 2003)
Sequelae of Ebola virus disease: the emergency within the emergency
A voracious creature The Lancet Volume 358, (December 2001)
Viral load and humoral immune response in association with disease severity in Puumala hantavirus-infected patients—implications for treatment  L. Pettersson,
Human asymptomatic Ebola infection and strong inflammatory response
Cold water immersion: sudden death and prolonged survival
Amanda Rojek, MBBS, Prof Peter Horby, FRCP, Dr Jake Dunning, MRCP 
Acute liver failure, multiorgan failure, cerebral oedema, and activation of proangiogenic and antiangiogenic factors in a case of Marburg haemorrhagic.
Excretion of infectious Zika virus in urine
Augusto Miyashiro, M.D., Soul J. Grosberg, M.D., Simon Wapnick, M.D. 
Sven Pischke, Patrick Behrendt, Michael P Manns, Heiner Wedemeyer 
Evidence for human immunodeficiency virus and Cryptococcus neoformans interactions in the pro-inflammatory and anti-inflammatory responses in blood during.
C-reactive protein concentration and the vascular benefits of statin therapy: an analysis of 20 536 patients in the Heart Protection Study  Heart Protection.
Low-technology approaches
Diagnosis of tuberculous meningitis with invasive pulmonary sampling
Volume 379, Issue 9822, Pages (March 2012)
Fibronectin concentrations in catheter sepsis
Volume 373, Issue 9672, Pages (April 2009)
Volume 92, Issue 1, Pages (July 1987)
Bedside Calibration Of Pulmonary Artery Catheters
Preventive malaria treatment for contacts of patients with Ebola virus disease in the context of the west Africa 2014–15 Ebola virus disease response:
Stem cell transplantation
Guillain-Barré syndrome
M. Honkinen, E. Lahti, R. Österback, O. Ruuskanen, M. Waris 
Luke A. Seaburg, MD, Hiroshi Sekiguchi, MD  CHEST 
Recombinant hirudin (lepirudin) as anticoagulant in intensive care patients treated with continuous hemodialysis  Karl-Georg Fischer, M.D., Andreas van.
Volume 386, Issue 10012, Pages (December 2015)
Unit 8: Forensic Serology
C1 esterase inhibitor concentrates and attenuated androgens
Presentation transcript:

Volume 385, Issue 9976, Pages 1428-1435 (April 2015) Severe Ebola virus disease with vascular leakage and multiorgan failure: treatment of a patient in intensive care  Timo Wolf, MD, Gerrit Kann, Prof Stephan Becker, MD, Christoph Stephan, MD, Hans-Reinhardt Brodt, MD, Philipp de Leuw, MD, Thomas Grünewald, MD, Thomas Vogl, MD, Prof Volkhard A J Kempf, MD, Prof Oliver T Keppler, MD, Prof Kai Zacharowski, MD  The Lancet  Volume 385, Issue 9976, Pages 1428-1435 (April 2015) DOI: 10.1016/S0140-6736(14)62384-9 Copyright © 2015 Elsevier Ltd Terms and Conditions

Figure 1 Haemodynamics and pharmacological interventions during the clinical course of capillary leak syndrome Figure shows course of the EVLWI and the SVRI as recorded by PiCCO monitoring system, and norepinephrine treatment and administration of FX06 (from day 11 to day 13). Inserts show chest radiographs from day 11 (start of FX06 treatment; A) and day 13 (B). The x-ray score is shown in grey, which demonstrates the regression of pulmonary capillary leak syndrome. EVLWI=extravascular lung water index. SVRI=systemic vascular resistance index. PiCCO=fibre optical thermodilution catheter technique. The Lancet 2015 385, 1428-1435DOI: (10.1016/S0140-6736(14)62384-9) Copyright © 2015 Elsevier Ltd Terms and Conditions

Figure 2 Ebola virus RNA PCR, anti-Ebola-virus IgG, and inflammatory parameters over the course of the illness Interleukin 6, C-reactive protein, Ebola virus RNA PCR (plasma, stool, and urine), and anti-Ebola-virus IgG titres are shown as a function of the days of disease. The patient was anuric from day 7 to 22, therefore the line for the urine PCR is interrupted. LOD=limit of detection. The Lancet 2015 385, 1428-1435DOI: (10.1016/S0140-6736(14)62384-9) Copyright © 2015 Elsevier Ltd Terms and Conditions

Figure 3 Laboratory parameters shown over the days of illness (days 6–30) (A) Blood count with platelet concentration and administered red blood cell concentrates. (B) Liver values and serum amylase concentrations. (C) Creatine kinase, albumin, and bilirubin. Numerical values are shown in the tables below the graphs. The Lancet 2015 385, 1428-1435DOI: (10.1016/S0140-6736(14)62384-9) Copyright © 2015 Elsevier Ltd Terms and Conditions